Synthes Investor Blasts $21B J&J Deal In Suit

Law360, New York (May 6, 2011, 6:29 PM EDT) -- A Synthes Inc. stockholder sued the company in Delaware on Thursday over its proposed $21.3 billion acquisition by Johnson & Johnson, saying the price is too low and takes unfair advantage of Synthes' legal woes following an illegal product testing scandal.

The Norfolk County Retirement System launched the putative class action against the Swiss medical device maker, its board and Johnson & Johnson in Delaware state court in an effort to block the transaction, which was formally announced April 27 and is expected to close in...
To view the full article, register now.